{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:56:18Z","timestamp":1759971378781,"version":"build-2065373602"},"reference-count":49,"publisher":"BMJ","license":[{"start":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:00:00Z","timestamp":1756339200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/N02995X\/1"],"award-info":[{"award-number":["MR\/N02995X\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012295","name":"NIHR Newcastle Biomedical Research Centre","doi-asserted-by":"publisher","award":["IS-BRC-1215-20001"],"award-info":[{"award-number":["IS-BRC-1215-20001"]}],"id":[{"id":"10.13039\/501100012295","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Thorax"],"accepted":{"date-parts":[[2025,7,31]]},"abstract":"<jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Critically ill patients commonly develop acquired neutrophil dysfunction, which increases susceptibility to intensive care unit-acquired infection (ICU-AI). This study aimed to assess whether interferon gamma (IFN-\u03b3) can restore function in dysfunctional neutrophils from critically ill patients and to uncover potential underlying mechanisms.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This was an observational cohort study. Neutrophils were isolated from whole blood donated by critically ill patients (n=31) in four separate teaching hospital intensive care units (ICUs). Neutrophils were subsequently treated with recombinant human IFN-\u03b3 or vehicle for 1\u2009hour following either Fc gamma receptor (Fc\u03b3R) blockade, selective inhibition of the gamma isoform of phosphoinositide 3-kinase (PI3K-\u03b3) or vehicle control for 30\u2009min. Neutrophil phagocytosis, bacterial killing, superoxide generation, phagocytic receptor expression and small Rho GTPase activity were assessed. Neutrophil dysfunction was defined as &lt;50% of cells ingesting 2 or more zymosan particles in a phagocytosis assay.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>IFN-\u03b3 significantly improved phagocytosis (control 36.5%, IFN-\u03b3 56.0%), bacterial killing (control 31.6%, IFN-\u03b3 82.1%) and superoxide generation (2.8-fold increase relative to control) in dysfunctional neutrophils. IFN-\u03b3 also increased the activity of the small GTPases, Rac and Cdc42 (2.4-fold and 1.5-fold increase relative to control, respectively) in dysfunctional neutrophils. Selective inhibition of PI3K-\u03b3 prevented the IFN-\u03b3-mediated improvement of phagocytosis (IFN-\u03b3 62.5%, with inhibitor 27.9%), bacterial killing (IFN-\u03b3 82.1%, with inhibitor 30.5%) and superoxide generation (IFN-\u03b3 2.8-fold change relative to control, 0.7 with inhibitor). The IFN-\u03b3-mediated improvement of bacterial killing in dysfunctional neutrophils was also prevented by Fc\u03b3R blockade (IFN-\u03b3 82.1%, Fc\u03b3R inhibition 28.7%).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>In critically ill patients with known acquired neutrophil dysfunction, ex vivo application of IFN-\u03b3 consistently improved a range of neutrophil effector functions.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/thorax-2025-223280","type":"journal-article","created":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T13:44:57Z","timestamp":1759931097000},"page":"thorax-2025-223280","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Interferon gamma applied ex vivo restores function to neutrophils from critically ill patients"],"prefix":"10.1136","clinical-trial-number":[{"clinical-trial-number":"nct10449048","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-8361-2049","authenticated-orcid":false,"given":"Cameron J","family":"Lake","sequence":"first","affiliation":[{"name":"Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3102-4294","authenticated-orcid":false,"given":"Jonathan","family":"Scott","sequence":"additional","affiliation":[{"name":"Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7525-2183","authenticated-orcid":false,"given":"Marie-H\u00e9l\u00e8ne","family":"Ruchaud-Sparagano","sequence":"additional","affiliation":[{"name":"Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John H","family":"Thompson","sequence":"additional","affiliation":[{"name":"Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5099-589X","authenticated-orcid":false,"given":"Fiona","family":"Dewar","sequence":"additional","affiliation":[{"name":"Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7534-7995","authenticated-orcid":false,"given":"Polina","family":"Yarova","sequence":"additional","affiliation":[{"name":"Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy","family":"Funston","sequence":"additional","affiliation":[{"name":"Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK"},{"name":"Respiratory Medicine, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7118-4941","authenticated-orcid":false,"given":"Richard CH","family":"Davidson","sequence":"additional","affiliation":[{"name":"Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK"},{"name":"Respiratory Medicine, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn M","family":"Musgrave","sequence":"additional","affiliation":[{"name":"Haematology, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen E","family":"Wright","sequence":"additional","affiliation":[{"name":"Anaesthesia and Critical Care, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9854-6674","authenticated-orcid":false,"given":"Ian","family":"Clement","sequence":"additional","affiliation":[{"name":"Anaesthesia and Critical Care, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alistair I","family":"Roy","sequence":"additional","affiliation":[{"name":"Integrated Critical Care Unit, Sunderland Royal Hospital, Sunderland, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4686-3368","authenticated-orcid":false,"given":"Wezi","family":"Sendama","sequence":"additional","affiliation":[{"name":"Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK"},{"name":"Respiratory Medicine, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1199-8406","authenticated-orcid":false,"given":"Jason","family":"Powell","sequence":"additional","affiliation":[{"name":"Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK"},{"name":"Department of Paediatric Otolaryngology, Great North Children\u2019s Hospital, Newcastle Upon Tyne, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Brooks","sequence":"additional","affiliation":[{"name":"Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3075-8344","authenticated-orcid":false,"given":"Chung Mun Alice","family":"Lin","sequence":"additional","affiliation":[{"name":"Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristen","family":"Davies","sequence":"additional","affiliation":[{"name":"Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5346-7411","authenticated-orcid":false,"given":"Thomas P","family":"Hellyer","sequence":"additional","affiliation":[{"name":"Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK"},{"name":"Anaesthesia and Critical Care, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9336-1723","authenticated-orcid":false,"given":"Anthony J","family":"Rostron","sequence":"additional","affiliation":[{"name":"Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK"},{"name":"Integrated Critical Care Unit, Sunderland Royal Hospital, Sunderland, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4731-7294","authenticated-orcid":false,"given":"A John","family":"Simpson","sequence":"additional","affiliation":[{"name":"Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK"},{"name":"Respiratory Medicine, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2025,8,28]]},"reference":[{"key":"2025082810251305000_thorax-2025-223280v1.1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(10)70258-9"},{"key":"2025082810251305000_thorax-2025-223280v1.2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-08-304667"},{"key":"2025082810251305000_thorax-2025-223280v1.3","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-018-5247-0"},{"key":"2025082810251305000_thorax-2025-223280v1.4","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-001-1143-z"},{"key":"2025082810251305000_thorax-2025-223280v1.5","unstructured":"European Centre for Disease Prevention and Control . Healthcare-associated infections acquired in intensive care units. In: ECDC. Annual epidemiological report for 2017. Stockholm: ECDC, 2019."},{"key":"2025082810251305000_thorax-2025-223280v1.6","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2017-211323"},{"key":"2025082810251305000_thorax-2025-223280v1.7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199102213240801"},{"key":"2025082810251305000_thorax-2025-223280v1.8","doi-asserted-by":"publisher","DOI":"10.1086\/422993"},{"key":"2025082810251305000_thorax-2025-223280v1.9","doi-asserted-by":"crossref","first-page":"3396","DOI":"10.1182\/blood.V89.9.3396","article-title":"Dose-dependent enhancements by interferon-gamma on functional responses of neutrophils from chronic granulomatous disease patients","volume":"89","author":"Ahlin","year":"1997","journal-title":"Blood"},{"key":"2025082810251305000_thorax-2025-223280v1.10","first-page":"499","article-title":"Interferon-gamma activates human neutrophil oxygen metabolism and exocytosis","volume":"63","author":"Cassatella","year":"1988","journal-title":"Immunology"},{"key":"2025082810251305000_thorax-2025-223280v1.11","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/jlb.53.3.301","article-title":"Oxidative priming of neutrophils by interferon-gamma","volume":"53","author":"Tennenberg","year":"1993","journal-title":"J Leukoc Biol"},{"key":"2025082810251305000_thorax-2025-223280v1.12","doi-asserted-by":"publisher","DOI":"10.1038\/nm0697-678"},{"key":"2025082810251305000_thorax-2025-223280v1.13","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-14-166"},{"key":"2025082810251305000_thorax-2025-223280v1.14","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-019-4526-x"},{"key":"2025082810251305000_thorax-2025-223280v1.15","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1164\/ajrccm.185.1.110","article-title":"Immune effects of interferon gamma in persistent staphylococcal sepsis","volume":"185","author":"Nalos","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"2025082810251305000_thorax-2025-223280v1.16","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1007\/s00134-023-07065-0","article-title":"Interferon gamma-1b for the prevention of hospital-acquired pneumonia in critically ill patients: a phase 2, placebo-controlled randomized clinical trial","volume":"49","author":"Roquilly","year":"2023","journal-title":"Intensive Care Med"},{"key":"2025082810251305000_thorax-2025-223280v1.17","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.4049\/jimmunol.140.10.3467","article-title":"Modulation of human polymorphonuclear leukocyte IgG Fc receptors and Fc receptor-mediated functions by IFN-gamma and glucocorticoids","volume":"140","author":"Petroni","year":"1988","journal-title":"J Immunol"},{"key":"2025082810251305000_thorax-2025-223280v1.18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0263370","article-title":"In vivo interferon-gamma induced changes in gene expression dramatically alter neutrophil phenotype","volume":"17","author":"Ambruso","year":"2022","journal-title":"PLoS One"},{"key":"2025082810251305000_thorax-2025-223280v1.19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01958"},{"key":"2025082810251305000_thorax-2025-223280v1.20","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.15.1.203"},{"key":"2025082810251305000_thorax-2025-223280v1.21","unstructured":"Cellagen Technology . AS-605240, PI3K inhibitor. n.d. Available: https:\/\/www.cellagentech.com\/AS-605240\/#:~:text=AS-605420%20is%20an%20orally-available%2C%20ATP%20competitive%20inihbitor%20of,300%20nM%20for%20alpha%2C%20beta%2C%20and%20delta%2C%20respectively"},{"key":"2025082810251305000_thorax-2025-223280v1.22","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.4049\/jimmunol.153.3.1254","article-title":"Neutrophil apoptosis is associated with a reduction in CD16 (Fc gamma RIII) expression","volume":"153","author":"Dransfield","year":"1994","journal-title":"J Immunol"},{"key":"2025082810251305000_thorax-2025-223280v1.23","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jaci.2015.07.036","article-title":"Exchange protein directly activated by cyclic AMP (EPAC) activation reverses neutrophil dysfunction induced by \u03b22-agonists, corticosteroids, and critical illness","volume":"137","author":"Scott","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"2025082810251305000_thorax-2025-223280v1.24","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/jlb.55.2.147","article-title":"A single assay for measuring the rates of phagocytosis and bacterial killing by neutrophils","volume":"55","author":"Hampton","year":"1994","journal-title":"J Leukoc Biol"},{"key":"2025082810251305000_thorax-2025-223280v1.25","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.2000603"},{"key":"2025082810251305000_thorax-2025-223280v1.26","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1182\/blood.V90.8.3187","article-title":"Increased phagocyte Fc gammaRI expression and improved Fc gamma-receptor-mediated phagocytosis after in vivo recombinant human interferon-gamma treatment of normal human subjects","volume":"90","author":"Schiff","year":"1997","journal-title":"Blood"},{"key":"2025082810251305000_thorax-2025-223280v1.27","doi-asserted-by":"publisher","DOI":"10.1007\/82_2010_40"},{"key":"2025082810251305000_thorax-2025-223280v1.28","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathol-011811-132445"},{"key":"2025082810251305000_thorax-2025-223280v1.29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0185956","article-title":"IFN-\u03b3 alters the expression of diverse immunity related genes in a cell culture model designed to represent maturing neutrophils","volume":"12","author":"Ellison","year":"2017","journal-title":"PLoS One"},{"key":"2025082810251305000_thorax-2025-223280v1.30","doi-asserted-by":"publisher","DOI":"10.1080\/21541248.2017.1304855"},{"key":"2025082810251305000_thorax-2025-223280v1.31","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.E08-05-0494"},{"key":"2025082810251305000_thorax-2025-223280v1.32","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201204-0645OC"},{"key":"2025082810251305000_thorax-2025-223280v1.33","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199506153322402"},{"key":"2025082810251305000_thorax-2025-223280v1.34","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-006-0204-8"},{"key":"2025082810251305000_thorax-2025-223280v1.35","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000000909"},{"key":"2025082810251305000_thorax-2025-223280v1.36","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.20883"},{"key":"2025082810251305000_thorax-2025-223280v1.37","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e3283536a93"},{"key":"2025082810251305000_thorax-2025-223280v1.38","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ijid.2017.03.013","article-title":"Adjuvant interferon-gamma immunotherapy in a patient with progressive cerebral Nocardia abscesses","volume":"59","author":"Leentjens","year":"2017","journal-title":"Int J Infect Dis"},{"key":"2025082810251305000_thorax-2025-223280v1.39","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(16)30541-2"},{"key":"2025082810251305000_thorax-2025-223280v1.40","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(14)70097-9"},{"key":"2025082810251305000_thorax-2025-223280v1.41","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(23)00468-X"},{"key":"2025082810251305000_thorax-2025-223280v1.42","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-023-01660-5"},{"key":"2025082810251305000_thorax-2025-223280v1.43","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105414","article-title":"Interferon-gamma driven elevation of CXCL9: a new sepsis endotype independently associated with mortality","volume":"109","author":"Giamarellos-Bourboulis","year":"2024","journal-title":"EBioMedicine"},{"key":"2025082810251305000_thorax-2025-223280v1.44","doi-asserted-by":"crossref","first-page":"4339","DOI":"10.2147\/OTT.S161544","article-title":"Polymorphism of IFN-\u03b3 +874T\/A associated with production of IFN-\u03b3 affects human papillomavirus susceptibility in rural women from Luohe, Henan, China","volume":"11","author":"Zhang","year":"2018","journal-title":"Onco Targets Ther"},{"key":"2025082810251305000_thorax-2025-223280v1.45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0121168","article-title":"Interferon Gamma +874T\/A Polymorphism Increases the Risk of Hepatitis Virus-Related Diseases: Evidence from a Meta-Analysis","volume":"10","author":"Sun","year":"2015","journal-title":"PLoS One"},{"key":"2025082810251305000_thorax-2025-223280v1.46","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200205-438BC"},{"key":"2025082810251305000_thorax-2025-223280v1.47","doi-asserted-by":"publisher","DOI":"10.1186\/cc13775"},{"key":"2025082810251305000_thorax-2025-223280v1.48","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/s12028-019-00773-w","article-title":"Incidence, Risk Factors, and Outcomes of Ventilator-Associated Pneumonia in Traumatic Brain Injury: A Meta-analysis","volume":"32","author":"Li","year":"2020","journal-title":"Neurocrit Care"},{"key":"2025082810251305000_thorax-2025-223280v1.49","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S2213-2600(19)30367-4","article-title":"Biomarker-guided antibiotic stewardship in suspected ventilator-associated pneumonia (VAPrapid2): a randomised controlled trial and process evaluation","volume":"8","author":"Hellyer","year":"2020","journal-title":"Lancet Respir Med"}],"container-title":["Thorax"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/thorax-2025-223280","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T13:45:01Z","timestamp":1759931101000},"score":1,"resource":{"primary":{"URL":"https:\/\/thorax.bmj.com\/lookup\/doi\/10.1136\/thorax-2025-223280"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,28]]},"references-count":49,"alternative-id":["10.1136\/thorax-2025-223280"],"URL":"https:\/\/doi.org\/10.1136\/thorax-2025-223280","relation":{},"ISSN":["0040-6376","1468-3296"],"issn-type":[{"value":"0040-6376","type":"print"},{"value":"1468-3296","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,28]]}}}